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pathology in C. elegans  
 
 
 
Waqar Ahmad
1
, Paul R Ebert
1
 
 
 
1
School of Biological Sciences, the University of Queensland, Brisbane 4072, 
Australia 
 
Correspondence: Paul R Ebert 
Phone: +61-733652973 
Email: p.ebert@uq.edu.au 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 2 
ABSTRACT 
Alzheimer’s disease (AD) is an age-related disease characterized by loss of memory and 
disrupted thinking that is associated with altered energy metabolism. Variants of an important 
enzyme of energy metabolism, dihydrolipoamide dehydrogenase (dld), have been genetically 
linked to late-onset AD. Moreover, reduced activity of DLD-containing enzyme complexes is 
associated with AD progression. To understand how energy metabolism influences AD 
progression, we exposed C. elegans expressing human Aβ peptide to the chemical inhibitor of 
DLD, 2-methoxyindole-5-carboxylic acid (MICA). Expression of human Aβ in C. elegans 
causes a variety of pathologies that can be used to monitor the efficacy of treatments against 
proteotixicity. We found that MICA alleviated the Aβ-induced paralysis and improved 
cholinergic neurotransmission in C. elegans that express Aβ in muscle cells. MICA also reduced 
both hypersensitivity to serotonin and perturbation of chemotaxis associated with neuronal 
expression of human Aβ. Furthermore, low doses of MICA helped to alleviate an Aβ-mediated 
decrease in fecundity. Protection against AD pathogenesis by MICA in the C. elegans model was 
associated with a decrease in Aβ oligomerization that could be reversed by the calcium 
ionophore, A23187. MICA also caused a decrease in oxidative stress, which could also 
contribute to the protective effect of MICA against Aβ toxicity.   
 
Key words: Alzheimer’s disease; neurodegeneration; amyloid beta; energy metabolism; 
dihydrolipoamide dehydrogenase (dld); C. elegans 
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1. Introduction  
Despite 100 years of research into Alzheimer’s disease (AD), the mechanism of disease 
initiation and progression is poorly understood. Overproduction and deposition of extracellular 
amyloid beta (Aβ) plaques is a key indicator of disease progression that is associated with 
cognitive impairment, neuronal loss and dementia (Castellani and Perry, 2014; Hyman et al., 
2012). In addition to the presence of Aβ plaques, reduced glucose energy metabolism and 
diminished activities of mitochondrial enzymes were found in brain tissue from late-stage AD 
patients (Mosconi, 2013; Shoffner, 1997; Vlassenko et al., 2012; Vlassenko et al., 2010). This 
decrease in energy metabolism could be (i) caused by disease progression as several late-stage 
postmortem studies found reduced energy metabolism in AD brain samples (Hooijmans et al., 
2007; Hoyer, 1991; Hoyer, 2000; Hoyer, 2004; Hunt et al., 2007), or (ii) a cellular response 
designed to limit damage due to Aβ-toxicity. Recent studies on post mortem brains at various 
stages of disease progression support the second interpretations as the down regulation of energy 
metabolism occurs too early in disease progression to be either a cause or consequence of tissue 
damage. Rather, the authors suggested that reduced energy metabolism is a protective measure 
designed to minimize neuronal activity, thereby decreasing the repair burden (Liang et al., 2012; 
Sun et al., 2012). Regardless of the interpretation, the evidence suggests an intimate link between 
AD and energy metabolism. 
The limited availability of AD affected brains from various stages of disease progression makes 
it difficult to investigate the role of energy metabolism in the process. However, a decrease in the 
activity of three dihydrolipoamide dehydrogenase-containing mitochondrial enzymes of energy 
metabolism, pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH) and 
branched chain α-keto acid dehydrogenase (BCKDH has been observed in AD (Gibson et al., 
2012; Shi et al., 2011; Simoncini et al., 2015). PDH links glycolysis to the TCA cycle and is a 
major control point in the regulation of aerobic respiration. Dichloroacetate, an activator of PDH 
induces oxidative phosphorylation and increases neuronal sensitivity to Aβ (Newington et al., 
2011). In contrast, the glucose analogue, 2-deoxy-d-glucose, inhibits both glycolysis and aerobic 
respiration, and reduces Aβ toxicity in mouse models as well (Vilalta and Brown, 2014; Yao et 
al., 2011). KDGHC is the rate-limiting step of the TCA cycle (Shoffner, 1997), and may have a 
similar role in suppressing the rate of aerobic respiration to reduce AD pathogenesis.  
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There is a variety of genetic evidence that links dihydrolipoamide dehydrogenase (DLD) 
to AD, including genetic variants associated with the disease in an Ashkenazi Jewish population 
(Brown et al., 2007). This supports the evidence from changes in the activity of DLD-containing 
enzyme complexes mentioned above. In the current study we use a chemical inhibitor of DLD 
enzyme activity known as 5-methoxyindole-2-carboxylic acid (MICA) to determine whether it 
also can alleviate Aβ toxicity in C. elegans that express human Aβ.  
MICA is a hypoglycemic agent that has been suggested as a possible drug to treat type 2 
diabetes (T2DM) (Bauman and Hill, 1968; Bauman and Pease, 1969; Gold, 1974; Schillinger 
and Loge, 1976; Ueki et al., 1985). Evidence indicates that the metabolic disease diabetes 
increases the risk of AD (Nguyen et al., 2014; Sebastiao et al., 2014; Verdile et al., 2015). As 
both AD and diabetes share many pathological features (Ahmad, 2013; Rosales-Corral et al., 
2015), it is possible that drugs used to lower hyperglycemia such as MICA might be effective in 
AD treatment. Although the exact mechanism whereby MICA alleviates hyperglycemia is not 
fully understood, MICA modifies cellular glucose levels by inhibiting glucose metabolism rather 
than insulin sensitivity (Arneric et al., 1984; Bauman and Pease, 1969; Hanson et al., 1969). 
Consistent with its action as an inhibitor of DLD, MICA inhibits the oxidation of the keto acid 
substrates of the enzyme complexes that contain DLD. This was reflected in reduced DLD 
enzyme activity in mitochondria of mice/ rats treated with MICA (Bauman and Hill, 1968; 
Haramaki et al., 1997). Inhibition of DLD by MICA was reversible by increasing intracellular 
calcium levels using the calcium ionophore A23187 (CaI) (Mitra and Shivaji, 2004; Nichols and 
Denton, 1995).  
There is no evidence regarding the role of MICA on neurodegeneration, though one 
possible mechanism by which MICA could influence neurodegeneration is by modifying energy 
metabolism. Our results showed that MICA protects against Aβ-mediated toxicity in C. elegans 
that express human Aβ. The protective effect of MICA is associated with a decrease in Aβ 
oligomerisation. In our study, the protective effects of MICA can be reversed using MICA 
inhibitor calcium ionophore A23187 (CaI).  
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2. Materials and Methods 
2.1. Nematode strains  
C. elegans strains used in this study are: wild type strain N2 (Bristol) long-lived, stress 
resistant dld-1 mutant, dld-1(wr4) (Cheng et al., 2003; Schlipalius et al., 2012), and the 
transgenic strains that express the human β-amyloid peptide in muscle cells. CL2006 (dvIs2 
[pCL12(unc-54/hu-Aβ42) + pRF4]), which produces the human Aβ42 peptide constitutively and 
CL4176 (smg-1
ts
 [myo-3/Aβ42 long 3/-UTR]), in which Aβ42 peptide expression is increased 
when the temperature is increased from 16
o
C to 23
o
C. The use of these strains as a worm model 
of AD was documented previously (Link, 1995). We also used strain CL2355 (dvIs50 [pCL45 
(snb-1::Abeta 1-42::3' UTR(long) + mtl-2::gfp] I), in which Aβ is also expressed under 
temperature control, though in this case the peptide is expressed pan-neuronally. The control 
strain for CL2355 was CL2122 (dvIs15(mtl-2::gfp) (Link, 1995; McColl et al., 2009; McColl et 
al., 2012; Wu et al., 2006). All the strains were obtained from the Caenorhabditis Genetics 
Center (CGC). 
2.2. Culture conditions 
Worms were maintained on nematode growth medium (NGM) seeded with E. coli OP50 
at 20
oC, except strains CL4176 and CL2355, which were maintained at 16°C to suppress Aβ 
expression. Synchronized cultures for bioassays were obtained using the standard bleaching 
procedure (Stiernagle, 2006). Briefly, gravid hermaphrodites were exposed to a freshly prepared 
alkaline bleach solution (0.75N NaOH + 1.5N NaOCl). The worms were incubated in the bleach 
solution for five minutes at room temperature followed by centrifugation at 1100 RPM for 1 
minute at room temperature. The supernatant was then discarded, and the pelleted eggs were 
resuspended in M9 buffer (6 g/L Na2HPO4; 3 g/L KH2PO4; 5 g/L NaCl; 0.25g/L MgSO4 •7H2O. 
Washing with M9 buffer was repeated 3 more times, after which the eggs were suspended in M9 
buffer and allowed to hatch overnight on an orbital shaker. The resulting L1 larvae were shifted 
to the fresh NGM agar plates seeded with E. coli to initiate growth. Aβ inducible transgenic 
worms were initially cultivated at 16
o
C for 36 hours after which the temperature was increased to 
23
o
C for 36 hours except for the paralysis assay for which the temperature was further increased 
to 25
oC to maximize the effect of the Aβ transgene. Aβ constitutive expressing worms were 
cultured at 20
o
CPhenotypes of the worms were monitored by visual observation under a 
microscope or quantified using the WormScan procedure (Mathew et al., 2012).  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 6 
2.3. Gene suppression by RNAi  
The E. coli strain SJJ_LLC1.3 (Source Bioscience), which expresses double-stranded 
RNA of the dld-1 gene, was fed to the worms to trigger dld-1 gene suppression (Kamath and 
Ahringer, 2003). Briefly, the bacteria were cultured in LB medium containing 100 µg/mL 
ampicillin overnight with shaking at 37
o
C. 300 µL of this bacterial culture was transferred to 
NGM plates containing 100 µg/mL ampicillin and 1 mM IPTG. The plates were incubated at 
25
o
C overnight to allow the bacteria to grow. Synchronised L1 worms were transferred to the 
bacterial plates and kept at 16
o
C for 36 hours. After a further 36 hours at 20 or 25
o
C, the worms 
were ready for use in gene expression, protein abundance and worm activity assays as described 
below. Mock gene suppression controls were treated in exactly the same way except that the 
worms were fed bacterial strain (HT115), which contained the plasmid vector without any 
specific gene fragment corresponding to a C. elegans gene.  
2.4. Paralysis assay 
Synchronized L1 stage CL4176 worms were transferred to NGM plates. To assess the 
role of chemical inhibition on paralysis behaviour of Aβ transgenic strains, different 
concentrations of chemicals were used in normal NGM plates. Transgenic worms were exposed 
to these chemicals continuously - before, during and after the induction of Aβ expression.  After 
36 hours at 16°C, worms were shifted to 25
o
C and scored for paralysis every 24 hours. Scoring 
began 24 hours after the temperature was raised to increase transgene expression. 
2.5. Aldicarb and levamisole assays  
Synchronized L1 worms were placed at 20°C on NGM plates or NGM plates 
supplemented with 5mM MICA that had been seeded with a lawn of OP50 E. coli. The worms 
were allowed to grow until they reached the L4 stage of development, at which time they were 
shifted to new NGM plates containing 1mM aldicarb, an ACh sterase inhibitor (Mahoney et al., 
2006) or 0.2mM levamisole, a cholinergic agonist (Lewis et al., 1987). Worms that had matured 
in the absence of MICA were exposed to the toxin without MICA and those exposed to MICA 
during maturation were, likewise, exposed to MICA during exposure to the toxin. The number of 
active worms was counted every half an hour until all worms became paralyzed. 
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2.6 Serotonin assay 
To determine the level of Aβ-induced serotonin hypersensitivity, serotonin (creatinine 
sulfate salt) was first dissolved in M9 buffer to 1 mM as described previously (Dosanjh et al., 
2010; Zhang et al., 2005). Synchronized worms were then washed with M9 buffer, and worms 
were transferred to 200 μl of the 1 mM serotonin solution in 12-well assay plates. The worms 
were scored as either active or paralysed after 5 minutes.  
2.7. Chemotaxis assay 
The chemotaxis assay was performed as described previously (Bargmann et al., 1993; 
Wu et al., 2006). Worms were placed on the center of the assay plate, which was then incubated 
for 1 hr at 20
oC. Attractant containing 1 μl of odorant (0.1% benzaldehyde in 100% ethanol) was 
added in a spot on one edge of the plate with 1 μl of 100% ethanol as a control on the opposite 
side of the plate. 1 μl of 1M sodium azide was added to each of the two spots to immobilize the 
animals once they had migrated to one or the other destination. The chemotaxis index (CI) was 
calculated as ([number of worms at the attractant location - number of worms at the control 
location]/total number of worms on the plate).  
2.8. Egg viability assay  
Transgenic Aβ strain CL2355 and its no- Aβ control strain CL2122 were synchronized as 
described under culture conditions above. After synchronization worms were grown at 16°C on 
NGM agar plates seeded with OP50 bacteria that either contained or did not contain 5 and/ or 
10mM MICA. Once the worms reached maturity at three days of age, 10 individuals in each of 
three replicates were transferred to fresh agar plates of the same composition and shifted to 23
o
C. 
Egg viability was determined as the percentage of eggs that were able to hatch over the next 3 
days.  
2.9. Chemical inhibition of DLD-1 with MICA in C. elegans 
Briefly, fresh NGM plates containing 1, 2.5, 5, 10, 25 and 50mM concentrations of 5-
methoxyindole-2-carboxylic acid (MICA) were prepared. As MICA is partially soluble in water, 
complete solubilization was achieved by adding a drop wise 5N sodium hydroxide until MICA 
becomes clearly soluble in water. Paralysis assay was scored for worms treated with and without 
MICA after 36 hr temperature up-shift at 25
o
C.   
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2.10. Reversal of MICA-mediated effects with a calcium ionophore 
Transgenic worms were synchronized and placed at NGM plates containing dld-1 RNAi 
and/ or 5mM MICA for 36 hours at 16
o
C and afterwards up-shifted to 23
o
C for an additional 36 
hours. L4 stage worms were next transferred to NGM plates containing different concentrations 
of calcium ionophore A23187 (CaI) ranging from 15-45µM with and without presence of 5mM 
MICA and/or dld-1 RNAi at 25
o
C. Worms were counted for paralysis until all worms became 
paralysed. To check whether absence or induction of calcium in NGM medium interferes with 
MICA-mediated protection, transgenic worms were placed on NGM plates containing 0. 1, 2.5, 
5, 7.5, and 10mM CaCl2 and assessed for paralysis. 
2.11. Oxidative stress measurement 
Reactive oxygen and reactive nitrogen species (ROS/RNS) levels were measured using 
2′,7′-dichlorofluorescein diacetate (DCF-DA) as described previously (Lee et al., 2010). Briefly, 
worms were synchronized and placed on NGM plates containing either 0mM or 5mM MICA that 
had been seeded with E. coli OP50 (Dosanjh et al., 2010). Worms were incubated for 36 hours at 
16
o
C followed by a temperature upshift for a further 36 hours at 23
o
C, after which they were 
washed with PBS three times and snap frozen in 250µl cell lysis solution. To prepare extracts, 
worms were sonicated followed by centrifugation at 14000rpm for 30 minutes. The supernatant 
was collected and protein in the extract was quantified using the Pierce Coomassie (Bradford) 
protein assay kit (Thermo Scientific) measured on a Nanodrop spectrophotometer. Supernatant 
containing 25µg of protein was pre-incubated with 250µM DCF-DA in 100µl of 1x PBS at 37
o
C 
for 1 hour. Fluorescence intensity (excitation wavelength 485nm and emission wavelength 
535nm) was measured using a SpectraMax M3 fluoremeter (Molecular Devices, Sunnyvale, 
USA). The background fluorescence of 250µM DCF-DA was subtracted from each sample.   
Hydrogen peroxide (H2O2) levels were measured spectrophotometrically using toluidine 
blue as described previously by Sunil et al. (Sunil and Narayana, 2008). Worm extracts were 
prepared and protein concentrations quantified as for the DCF-DA assay protocol. For each 25µg 
of protein we added 20µl 2% potassium iodide, 20µl 2M HCl, 10µl 0.01% toluidine blue and 
40µl 2M sodium acetate. The contents were mixed and absorbance was measured at 628nm 
against a standard curve based on known concentrations of H2O2.  
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2.12. Western Blotting of Aβ  
Aβ was identified in C. elegans strains by immunoblotting after separation of proteins on 
a 16% Tris-Tricine gel. A standard western blotting protocol was used except that SDS was 
omitted from the transfer buffer (Mahmood and Yang, 2012). Briefly, synchronized L2 worms 
were incubated at 23
o
C for 36h and then washed with distilled water, and quickly frozen in liquid 
nitrogen. Flash frozen worms were either stored at -80
o
C or sonicated twice in the ice-cold cell 
lysis buffer (50 mM HEPES, pH 7.5, 6 mM MgCl2, 1mM EDTA, 75 mM sucrose, 25 mM 
benzamide, 1 mM DTT and 1% Triton X-100 with proteinase and phosphatase inhibitors 1:100 
ratio). After sonication, the lysate was centrifuged at 10000 rpm to remove insoluble debris and 
total protein in the supernatant was determined using the Pierce Coomassie (Bradford) protein 
assay kit (Thermo Scientific) measured on a Nanodrop spectrophotometer. From each sample, 
~100 µg of total protein was precipitated with acetone and dissolved in Novex® Tricine SDS 
sample buffer (LC1676, Invitrogen) by heating to 99°C for 5 minutes. Samples were subjected to 
gel electrophoresis at 100V for 2.5 hrs using separate cathode (100mM Tris, 100mM Tricine, 
0.1% SDS, pH 8.3) and anode (0.2M Tris, pH 8.8) running buffers. Proteins were wet transferred 
onto nitrocellulose membranes by electroblotting in the transfer buffer (35 mM glycine, 48 mM 
Tris (pH = 8.8) and 20% methanol) for 70 min at 100V and stained with Ponceau S (0.1% 
Ponceau S in 1% acetic acid) for 5 minutes following de-staining with 10% acetic acid (5 
minutes) and washing under water (5 minutes). The membranes were blocked overnight in 5% 
skim milk at 4
o
C to prevent non-specific binding of antibodies.  
To detect Aβ, the primary antibody binding was done using the mouse Aβ monoclonal 
antibody 6E10 (Covance) at 1:1000 dilution in TBS (50mM Tris, 150mM NaCl, pH 7.6) 
containing 1% skim milk for 3-4 hours at room temperature followed by three washes with TBS-
T of five minutes each. For DLD-1 detection, anti-lipoamide dehydrogenase antibody 
(ab133551) was used. The same procedure was repeated for DLD-1 detection except 5%BSA in 
1X TBST was used for anti-body detection.   
Anti-mouse IgG alkaline phosphatase antibody produced in goat (A3562, Sigma), and 
anti-rabbit IgG alkaline phosphatase antibody produced in goat (A3687, Sigma were used as 
secondary antibody at 1:10000 dilutions in TBS containing 1% skim milk or in 1% BSA in 1X 
TBST. Secondary antibody staining was done for 1 hour at room temperature. After washing the 
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membrane with TBST, the proteins were detected using the BCIP/ NBT substrate system 
(Sigma) or the BCIP/ NBT kit (002209) from Life Technologies dissolved in 1M Tris (pH 9.0). 
2.13. Quantitative RT-PCR and immunoblotting confirmation 
Aβ mRNA levels in transgenic worms either exposed or not exposed to 5mM MICA 
were quantified using Rotor-Gene Q (QIAGEN) thermocycler. Briefly, total RNA was extracted 
using the acid-phenol (Trizol) method and converted to single-stranded cDNA using Invitrogen 
SuperScript cDNA synthesis kit following the prescribed protocol. Gene-specific primers were 
as follow: Aβ forward primer CCGACATGACTCAGGATATGAAGT, Aβ reverse primer 
CACCATGAGTCCAATGATTGCA; dld-1 forward primer GATGCCGATCTCGTCGTTAT, 
dld-1 reverse primer TGTGCAGTCGATTCCTCTTG; act-1 forward primer 
CGCTCTTGCCCCATCGTAAG, act-1 reverse primer CTGTTGGAAGGTGGAGAGGG; 
gapdh-2 forward primer TTCTCGTGGTTGACTCCGAC, and gapdh-2 reverse primer 
AGGGAGGAGCCAAGAAGGTAAC.  The PCR conditions were 95
o
C for 30 s followed 35 
cycles of 95
o
C for 20 s, 55
o
C for 30 s, and 72
o
C for 40 s. Following amplification, a melting 
curve was determined during a temperature ramp from 72
o
C to 95°C. For qPCR quantification, 
SYBR
®
 Green JumpStart
TM
 ReadyMix
TM
 (Sigma) was used.  
2.14. Statistical analysis 
GraphPad prism 7.03 was used for graph production and statistical analysis. Paralysis 
curves were compared using the log-rank (Mantel-Cox) test. Pairwise treatments were analyzed 
for statistical significance by independent student’s t-test. Anova was used to compare statistical 
difference among 3 or more groups. A p value of less than 0.05 was considered statistically 
significant.  
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3. Results 
The influence of energy metabolism on Alzheimer’s disease is still unclear though a 
significant correlation exists between a decline in glucose metabolism and the progression of 
late-onset AD (Ahmad, 2013; Akhtar et al., 2016; Furst and Lal, 2011; Hoyer, 1991; Hoyer, 
2000; Nilsen et al., 2011; Vilalta and Brown, 2014; Yao et al., 2011). Two mutually exclusive 
hypotheses have been proposed, that declining energy metabolism exacerbates disease 
progression or that it is a protective response to AD that slows progression of the disease. In 
work that we will publish elsewhere, we found that suppression of energy metabolism by RNAi 
of the dld-1 gene results in significant protection against Aβ proteotoxicity in C. elegans models 
of AD. Based on this finding, we reasoned that the DLD-1 enzyme inhibitor 2-methoxyindole-5-
carboxylic acid (MICA) might act as a small molecule therapeutic agent in the treatment of AD. 
Here we show that MICA reduces Aβ-mediated, age-dependent paralysis, impaired ACh 
neurotransmission, and impaired behaviour in the AD models.  
3.1. MICA up to 10mM does not alter dld-1 gene or protein expression 
MICA is a known inhibitor of the DLD enzyme (Bauman and Hill, 1968; Hanson et al., 
1969), but its effect on dld-1 transcript and protein levels is not known. We find that dld-1 RNAi 
was able to suppress the dld-1 transcript levels in the CL4176 strain by approximately 75% 
(p=0.015) (Fig. 1A) and suppressed DLD-1 protein abundance by approximately 70% (Fig. 1B, 
p=0.006). Exposure to 5mM MICA caused no significant change in transcript abundance 
(p=0.172). Likewise, concentrations of MICA from 1-10mM have no significant effect on DLD-
1 protein expression (p>0.05). However, 15mM MICA causes a significant increase in protein 
abundance (p=0.004) (Fig. 1C).  
3.2. MICA alleviates Aβ-induced pathology in transgenic C. elegans  
While MICA did not affect either dld-1 gene expression or protein abundance, it is 
known to inhibit DLD protein activity and to reduce downstream energy metabolism (Bauman 
and Hill, 1968; Hanson et al., 1969). The suppression of dld-1 by RNAi in C. elegans is 
associated with stress resistance (Butler et al., 2013; Schlipalius et al., 2012). This suggests that 
MICA will be a useful tool with which to investigate the relationship between metabolic rate and 
AD, using Aβ-toxicity as an indicator.  
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Aβ-mediated toxicity in worms is associated with age-dependent paralysis (Link, 1995). 
To determine whether MICA can delay Aβ-mediated paralysis, worms of strain CL4176 that 
contain a temperature inducible Aβ transgene were exposed to MICA continuously, before, 
during and after induction of Aβ expression. The time to 100% paralysis of the 0mM MICA 
control was 48 hours. Both 5mM and 10mM MICA significantly delayed the time to paralysis, 
though the 5mM treatment had the greatest effect (120 hours, p<0.0001). Interestingly, outside 
the therapeutic range, at low (2.5mM) and at high (25mM) concentrations, MICA had no effect 
on paralysis (p>0.05). At an extremely high dose (50mM), MICA worms ceased moving within 
24 hours (p=0.01) (Fig. 2A). Suppression of the dld-1 gene by RNAi had a protective effect even 
greater than that of 5mM MICA (Fig. 2A). 
As DLD-1 inhibition by MICA and suppression of the dld-1 gene by RNAi can both 
alleviate Aβ-mediated paralysis, we tested the two treatments in combination to determine 
whether the effect of MICA was mediated through DLD-1. To accomplish this, we compared the 
effect after 24 hours of 5mM MICA and RNAi of the dld-1 gene individually as well as in 
combination. Suppression of the dld-1 gene by RNAi doubled the number of active worms at 24 
hours. MICA also increased the percentage of active worms to a level that, while lower, was 
statistically indistinguishable from the percentage of worms that remained active in response to 
dld-1 gene suppression (67.5 ± 3.7 vs 85.5 ± 3.5, p=0.071) (Fig. 2B). The effect of the combined 
treatment was essentially identical to that of dld-1 RNAi but was significantly more protective 
than MICA alone (67.5 ± 3.7 vs 88.5 ± 4.9 (p=0.035). Thus, the protective effect of MICA is 
likely mediated through its effect on the DLD-1 enzyme. 
Aβ expression in worms impairs cholinergic neurotransmission and associated functions 
like muscle contraction and movement (Brown and Luo, 2009). Because the presence of Aβ 
blocks the release of acetylcholine (Ach), worms that express Aβ are protected against the acute 
paralysis that is caused by hyperexcitation of the cholinergic system. Thus, acute paralysis 
caused by two cholinergic agonists, aldicarb, an ACh esterase inhibitor (pre-synaptic effect) and 
levamisole, a receptor agonist (post-synaptic effect) is delayed in strains that express Aβ 
(Diomede et al., 2014; Oh and Kim, 2017; Saharia et al., 2012; Xin et al., 2013). To check 
whether MICA restores normal ACh neurotransmission (i.e. susceptibility to acute paralysis by 
cholinergic agonists), the CL2006 strain that constitutively expresses Aβ in muscle cells was 
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exposed to aldicarb or levamisole. In our study, MICA restored sensitivity to aldicarb, reducing 
the time to paralysis by 33% compared to worms that were not exposed to MICA (from 180 to 
120 min) (p<0.0001) (Fig. 3A). In contrast, paralysis due to the postsynaptic receptor agonist, 
levamisole, was only decreased by 12.5% (from 240 min to 210 min) (p=0.0001) after MICA 
treatment (Fig. 3B). As MICA did not change the paralysis profile of either wild type or dld-1 
mutated worms (Fig. S1), the increase in ACh neurotransmission is most likely the result of a 
decrease in cholinergic inhibition by Aβ. 
We next determined whether MICA was also able to reverse the negative effects of Aβ 
expression in the nervous system using strain CL2355 and its matched control CL2122. In AD, 
Aβ is primarily expressed in neurons. Assays for cellular dysfunction due to neuronal expression 
of Aβ in C. elegans include impaired chemotaxis, serotonin hypersensitivity, egg laying and egg 
hatching (Machino et al., 2014; Wu et al., 2006).  
Neuronal expression of Aβ in strain CL2355 significantly reduced chemotaxis toward the 
attractant benzaldehyde compared to non-Aβ control worms (Chemotaxis index, 0.062±0.014 vs 
0.219±0.06, p=0.004). MICA exposure significantly improved chemotaxis of strain CL2355 
(0.062±0.014 vs 0.138±0.026, p=0.018), which was not statistically distinguishable from that of 
the MICA treated control strain (0.138±0.026 vs 0.185±0.035, p=0.12) (Fig. 5.4A). However, 
MICA treatment did not affect chemotaxis in the non-Aβ control worms CL2122 (0.185±0.035 
vs 0.219±0.06, p=0.70). 
C. elegans exposed to exogenous serotonin become paralyzed. Neuronal expression of 
Aβ (CL2355) increases sensitivity to serotonin, exacerbating paralysis relative to the matched 
control (CL2122) (70.6±4.5% vs 36.3±5.5%, p=0.007) (Wu et al., 2006). MICA did not change 
the paralysis level of the CL2122 worms (36.3±5.5% vs 40.3±6.3%, p=0.859) but was able to 
reduce paralysis in strain CL2355 in which Aβ was expressed (70.6±4.5% vs 52.6±8.1, p=0.01). 
The fraction of CL2355, MICA-treated worms that were paralysed, however, did not return to 
the CL2122 MICA-treated control level (52.6±8.1 vs 40.3±6.3%, p=0.044) (Fig. 5.4B).  
 The presence of Aβ is also known to decrease fecundity and delay egg hatching in C. 
elegans (Machino et al., 2014), so we tested whether MICA could reverse these effects. The 
fecundity of the Aβ strain CL2355 was indeed lower than its matched control (157±8 vs 270±8, 
p<0.0001) (Fig. 4C). 5mM MICA significantly improved fecundity in CL2355 worms (157±8 vs 
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198±8, p=0.004), but this increase failed to restore fecundity to the level of the untreated control 
(198±8 vs 270±7, p=0.0001). 5mM MICA also reduced fecundity of CL2122 control worms 
(270±7 vs 222±15, p=0.01) and 10mM MICA caused a decrease in fecundity for both strains 
(Fig. S2). It is likely that at higher doses, MICA inhibits energy metabolism due to inhibition of 
DLD-1, which triggers the reduction in egg laying independently of Aβ. 
 Aβ expression also impedes egg hatching in worms with only 13.7% of control (CL2122) 
eggs remaining unhatched after 24 hrs compared to 61.8% of eggs from the Aβ transgenic strain 
(CL2355) (p<0.0001) (Fig. 4D). Hatching was greatly improved in the CL2355 strain after 
exposure to 5mM MICA, with only 27.5% of CL2355 eggs remaining unhatched after 24 hours 
(p=0.001). By day two, 8% of control eggs and 37.6% of eggs from the Aβ transgenic strain 
remained unhatched (p=0.0009). In contrast, Aβ transgenic worms treated with 5mM MICA 
showed a significant improvement with only 17.8% (p=0.007) of eggs remaining unhatched. In 
the Aβ transgenic strain, egg hatching was impeded such that 17.5% were still unhatched even 
by day three.  
 
3.3. Protective effects of DLD-1 inhibition can be reversed by calcium ionophore (CaI) 
Although we found that MICA can protect against Aβ, it is toxic and has a narrow 
effective dose range (Hanson et al., 1969; Schillinger and Loge, 1976). If MICA is to be used 
effectively against AD, it is imperative that we understand the basis of its toxicity. In this regard, 
MICA is known to influence calcium signaling, as inhibition of DLD by MICA causes a 
decrease in intracellular calcium that can be reversed by the calcium ionophore A23187 (CaI) 
(Panneerdoss et al., 2012). This finding raises the possibility that CaI might also reverse the 
effects of dld-1 inhibition on strains that express Aβ. To test this hypothesis, we assessed the 
effect of CaI on Aβ-mediated paralysis alone or in the presence of either 5mM MICA or dld-1 
gene suppression by RNAi 
Doses of CaI up to 30 µM have no effect on Aβ-mediated paralysis, whereas higher doses 
increased paralysis (Fig. 5A), a result that is consistent with the antagonistic effect of CaI on 
MICA. For Aβ-expressing worms treated with a maximally protective dose of 5 mM MICA, a 
CaI dose of 30µM partially reversed the protective effect. At 35µM CaI, paralysis was equivalent 
to that observed in Aβ expressing control worms without MICA treatment (Fig. 5B). 35µM CaI 
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also completely reversed the protection against Aβ expression provided by suppression of the 
dld-1 gene through RNAi (Fig. 5C). Increasing the calcium in the growth medium from 1mM to 
10mM had no effect on the Aβ-mediated paralysis phenotype (Fig. 5D). 
 
3.4. MICA and CaI modulate Aβ protein oligomerization without affecting Aβ peptide levels 
 
In our study, MICA successfully reduced the Aβ toxicity in worms that express Aβ in 
either muscle cells or neurons of C. elegans. MICA is known to inhibit DLD-1 enzyme activity 
and CaI reverses this suppression, but we wished to confirm that there were no confounding 
effects on Aβ gene expression that would lead us to misinterpret how MICA and CaI might 
influence the C. elegans model of Aβ. Quantitative PCR revealed no change in mRNA levels of 
the Aβ transgene after RNAi-mediated suppression of the dld-1 gene, treatment with MICA, or 
exposure to CaI (Fig. 6A).  
We also monitored the effect of dld-1 RNAi, MICA and CaI on ex vivo oligomerization 
of Aβ, because an increase in oligomerization induced by CaI is one way that it could overcome 
the protective effect of the other treatments (Giuffrida et al., 2009). We used the Aβ specific 
antibody (6E10) on western blots to detect Aβ monomers and oligomers (Fig. 6B). Figure 6B 
also represents quantification of respective band intensities normalized to the amount of β-actin 
in each protein sample from three independent experiments.  
Our results showed that MICA significantly increases the abundance of Aβ monomers 
when compared to control (~4kDa: 0.24±0.09 vs 0.53±0.07, p=0.016), while simultaneously 
decreasing the abundance of Aβ oligomers ~9kDa (0.48±0.08 vs 0.17±0.0.05, p=0.002) and 
~16kDa (0.33±0.04 vs 0.07±0.0.05, p=0.002) in the transgenic Aβ expressing strain CL4176. 
Similar results were observed in CL4176 worms in which the dld-1 gene had been suppressed by 
dld-1 RNAi. There was an increase in ~4kDa monomers (0.24±0.09 vs 0.68±0.07, p=0.003) and 
reduction in ~9kDa (0.48±0.08 vs 0.21±0.04, p=0.002) and ~16kDa (0.33±0.04 vs 0.07±0.03, 
p=0.002) oligomers.  
Whereas dld-1 RNAi and MICA each cause an increase in monomer, simultaneous 
exposure to 35μM CaI caused a decrease in oligomers, reversing the protection resulting from 
the original interventions. Thus, the levels of 4kDa monomers is decreased and 9kDa Aβ 
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oligomers increase to the level of the CL4176 control strain without intervention (Fig.6B). It was 
interesting that on its own, 35μM CaI does not increase Aβ oligomerization, but rather decreases 
Aβ ~16kDa oligomers (0.30±0.04 vs 0.02±0.07, p=0.002) and ~20kDa (0.33±0.04 vs 0.07±0.04, 
p=0.012) when compared to control. No effect was observed on 9kDa oligomers. At the same 
time, the abundance of ~4kDa monomer increased from 0.24±0.09 to 0.65±16, p=0.02.  
3.5. MICA reduces oxidative stress in Aβ expressing worms 
Another possible mechanism through which MICA could decrease the toxicity of Aβ is 
via a decrease in reactive oxygen or reactive nitrogen species (ROS/RNS) as these reactive 
molecules can induce aggregation of Aβ (Goldsbury et al., 2008; Misonou et al., 2000; Pajak et 
al., 2016). DLD itself can generate significant amounts of ROS (superoxide), so suppression of 
DLD activity could lead to a decrease in superoxide production (Murphy, 2009; Tahara et al., 
2007). To explore this possibility, we measured the cellular ROS/RNS levels using DCF-DA. 
Our results showed that MICA lowered the ROS/RNS levels of the Aβ-expressing, strain 
CL4176 (5266.5±883vs1610.6±838.5, p<0.001).   
The superoxide that is produced by DLD is readily converted into hydrogen peroxide 
(H2O2). Quantification of H2O2 is therefore a good indicator of DLD-generated oxidative stress. 
We measured the H2O2 levels in the worm’s extracts spectrophotometrically using toluidine blue. 
Addition of MICA significantly lowered the H2O2 levels in Aβ expressing worms when 
compared to non-treated (24.1±1.4 vs 12.2±0.6, p<0.001). This MICA-mediated decrease in 
ROS may also protect against Aβ-toxicity. 
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4. Discussion 
MICA is a potent inhibitor of dihydrolipoamide dehydrogenase, a key enzyme of energy 
metabolism that is implicated in Alzheimer’s disease. Specifically, the activities of two enzyme 
complexes that contain DLD as a subunit, are diminished in AD (Gibson et al., 2012; Gibson et 
al., 1988; Gibson et al., 1998; Mastrogiacoma et al., 1996). This may implicate these complexes 
in the pathology of AD or may suggest that their suppression is a protective response to AD 
pathology. Mutation in the dld-1 gene in C. elegans or suppression of the gene by RNAi results 
in stress resistance and an extended lifespan (Butler et al., 2013; Cheng et al., 2003; Schlipalius 
et al., 2012), which supports the latter hypothesis. We have used MICA to determine whether 
inhibition of the DLD enzyme influences Aβ pathology, a hallmark of AD, and a progressive, 
age-related human disease.  
In our study, RNAi-mediated suppression of the dld-1 gene resulted in a decrease in both 
dld-1 transcript and protein levels. In contrast, ≤10mM MICA did not change the DLD protein 
expression levels when compared to control while a dose of 15mM MICA triggered an increase 
in DLD-1 protein levels, presumably reflecting an attempt to restore enzyme activity levels in the 
face of direct inhibition by MICA. Despite the elevated protein abundance following treatment 
with MICA, there was an increase in the ratio of non-toxic Aβ monomers to toxic oligomers 
(Diomede et al., 2014; Dosanjh et al., 2010; Dostal and Link, 2010; Link, 1995; McColl et al., 
2012; Wu and Luo, 2005; Wu et al., 2006). 
Consistent with the decrease in oligomerisation of Aβ in response to MICA, we observe 
that MICA can reduce the severity of symptoms triggered by Aβ. Specifically, MICA delayed 
the time-dependent paralysis induced by expression of Aβ in muscle. Such paralysis could be 
due to Aβ-mediated synaptic defects via inhibition of the cholinergic neurotransmission essential 
for neuromuscular activity (Brown and Luo, 2009; Oh and Kim, 2017; Wu et al., 2006; Xin et 
al., 2013). We found that MICA did indeed restore sensitivity to activators of cholinergic 
signaling, which we interpreted as suppression of DLD enzyme activity by MICA, resulting in a 
decrease in oligomerisation of Aβ, leading to improvement in cholinergic neurotransmission. 
The protective effect of MICA was not apparent at higher doses through a mechanism 
independent of Aβ. The most likely interpretation is that MICA at high doses, had a deleterious 
effect on DLD-mediated energy metabolism, or caused other side-effects unrelated to DLD. 
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We also tested the ability of MICA to positively influence cellular function when Aβ was 
expressed in C. elegans neuronal cells. Aβ expression is associated with neuronal dysfunction 
leading to reduced chemotaxis, serotonin hypersensitivity, impaired fecundity and delayed egg 
hatching (Machino et al., 2014; Wu et al., 2006), each of which is influenced by impaired ACh 
signaling (Rand, 2007). Just as MICA restored cholinergic neurotransmission in worms that 
express Aβ in muscle cells, we reasoned that MICA should also reduce Aβ-mediated toxicity in 
worms that express Aβ in neurons. In our previous study, we found that metformin, a well-
known hypoglycemic agent, improved chemotaxis and restored normal serotonin-sensitivity in 
worms that express Aβ in neurons (Ahmad and Ebert, 2016). Similar findings were observed for 
MICA in this study showing that the two metabolically active compounds are able to achieve the 
same therapeutic endpoint. Aβ oligomerization and accumulation inhibits cholinergic 
neurotransmission, impairs calcium signaling and blocks serotonin re-uptake (Wu et al., 2006), 
each of which cause hypersensitivity to serotonin. Chemotaxis in C. elegans is directly 
controlled by serotonin, making it a suitable indicator of proper serotonin signaling (Tsui and 
van der Kooy, 2008). MICA has no affinity for serotonin receptors (Appel-Dingemanse, 2002) 
and has no effect on serotonin sensitivity in control nematodes that do not express Aβ. Thus, the 
ability of MICA to enhance chemotaxis in transgenic worms is most likely due to a decrease in 
Aβ pathology leading to restoration of normal ACh neurotransmission, and thereby, normal 
serotonin sensitivity as well. 
Aβ expression also reduced fecundity and delayed egg hatching in C. elegans (Machino 
et al., 2014). MICA partially reversed the effect of Aβ expression, but also negatively affected 
these traits in control worms that did not express Aβ. The overall effect of MICA on 
reproduction was deleterious. MICA has also been found to decrease fertility in mammals 
(Panneerdoss et al., 2012), so  a similar observation in worms is not surprising. We postulate that 
the increase in fertility of worms that express Aβ is due to modulation of Aβ toxicity caused by 
oligomerisation, whereas higher doses of MICA are deleterious because they disrupt DLD 
function and thereby the energy balance too severely.  
The preceding results demonstrate that MICA can reduce Aβ-proteotoxicity in C. 
elegans. To elucidate possible mechanisms, we assessed the role of calcium signaling on the 
ability of MICA to protect against Aβ-toxicity, including effects on the production and 
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oligomerization of Aβ peptide. Calcium is known to positively regulate the activity of DLD-
containing enzyme complexes, so could be expected to counter the beneficial effects of complex 
inhibition due to exposure to MICA. A calcium ionophore (CaI) acts by releasing calcium from 
cellular stores, thereby increasing intracellular calcium levels (Bauman and Hill, 1968; 
Panneerdoss et al., 2012). This provides a way to test the interaction between MICA-mediated 
DLD inhibition and calcium-mediated activation of the DLD-containing enzyme complexes. 
Indeed, CaI increased Aβ-mediated paralysis dose dependently and reversed the protective 
effects of dld-1 gene suppression. CaI was previously found to reverse the ability of MICA to 
inhibit DLD enzyme activity in acrosomes (Kumar et al., 2008; Panneerdoss et al., 2012). The 
same mechanism could explain our observations. Impaired calcium homeostasis in aging brains 
is well documented, suggesting that this could exacerbate age-related neurodegeneration 
(Mattson and Chan, 2001; Woods and Padmanabhan, 2012). We also tested the effect of an 
increase in extracellular calcium on Aβ-proteotoxicity, but increasing the calcium in the growth 
medium from 1mM to 10mM had no effect on the Aβ-mediated paralysis phenotype. This 
indicates that the external calcium pool has minimal effect on intracellular calcium levels in the 
worm.  
Given that CaI reversed the protective effect of DLD inhibition against Aβ-mediated 
paralysis, we also examined the effect of CaI on oligomerization of Aβ. We found that CaI 
induced Aβ oligomerization despite suppression of the dld-1 gene by RNAi. This suggests that 
enzyme activation by Ca
2+
 can reverse protection against the toxicity of Aβ provided by 
suppression of the dld-1 gene. Surprisingly, exposure to CaI reduced oligomerization of Aβ in 
worms that expressed Aβ, but in which the dld-1 gene was not suppressed by RNAi.  
In addition to a decrease in Aβ oligomerization, a decrease in oxidative stress could also 
be a protective mechanism resulting from DLD inhibition by MICA in the Aβ-expressing strain, 
as ROS is negatively coorelated with Aβ aggregate formation (Misonou et al., 2000; Pajak et al., 
2016). DLD itself can generate a significant amount of ROS (superoxide). As such, suppression 
of DLD activity could lead to a decrease in superoxide production and thereby a decrease in 
cellular oxidative stress. The superoxide radical (O2
.-
) is readily converted into H2O2 or reacts 
with nitrogenous species to form reactive nitrogen compounds (Murphy, 2009; Tahara et al., 
2007). In our study, MICA treatment decreased overall ROS/RNS levels as detected by DCDFA 
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and also decreased the amount of H2O2. A recent study in rats also observed same findings where 
MICA not only decreased H2O2 levels but also reduced protein carbonylation and lipid 
peroxidation (Wu et al., 2018). The decrease in ROS/RNS in response to inhibition of DLD 
activity provides another probable mechanism to explain the protective effect of MICA against 
Aβ-toxicity. Overall, the protective effect of MICA seems to occur through inhibition of Aβ 
oligomerization either by a decrease in oxidative stress, or by modulation of calcium signaling. 
Although we did not assess the role of CaI on ROS/RNS levels, it may be that CaI also induces 
oxidative stress as reported in previous studies (Petersen et al., 2000; Przygodzki et al., 2005; 
Yamazaki et al., 2009). 
 Although MICA was first proposed as a drug for diabetes 65 years ago, development of 
this compound has not been pursued due to significant side-effects. We demonstrate that MICA 
provides significant protection against Aβ-mediated pathology in the C. elegans model of AD. 
This suggests that the wide array of commercially available MICA derivatives or other 
compounds that target DLD or the DLD-containing enzyme complexes should be investigated as 
potential therapeutic compounds for the treatment of AD.   
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Figure legends 
Fig. 1. MICA does not affect dld-1 transcript levels. Transcript and protein quantification was 
carried out on synchronized L4 stage C. elegans of strain CL4176 that expresses Aβ in muscle. 
The nematodes were either subjected to RNAi of the dld-1 gene or treated with MICA at the 
indicated concentrations. The nematodes were initially cultured for 36 hrs at 16
o
C, followed by 
36 hrs at 25
o
C to induce transgene expression before RNA or protein extraction. A) 
Quantification of relative dld-1 mRNA levels by RT-PCR, in CL4176, CL4176 in which the dld-
1 gene has been suppressed by RNAi or CL4176 treated. with 5mM MICA. B) Immunoblot 
assay of total soluble protein from cell lysate of CL4176 or CL4176 in which the dld-1 gene has 
been suppressed by RNAi. DLD-1 protein levels were detected using the anti-DLD antibody and 
were normalized to tubulin levels using an anti-tubulin antibody. C) Immunoblot assay of total 
protein extracted from CL4176 treated with different concentrations of MICA. Graphs show 
results from three independent replicates. Bars = Mean ±SD.  
 
Fig. 2. MICA reduces paralysis due to Aβ expression in muscles of C. elegans. A) L1 nematodes 
of strain CL4176 Temperature inducible Aβ expressing worms were cultured on medium 
containing MICA at concentrations ranging from 2.5 to 50mM. Protection against paralysis was 
assessed relative to protection due to RNAi of the dld-1 gene [(+) dld-1] or the untreated strain 
[CL4176]. T=0 refers to the time of induction of Aβ expression by temperature up-shift to 25oC. 
B) The effect of co-treatment with 5mM MICA and dld-1 suppression by RNAi after 24 hrs of 
temperature induction. Bars=mean±SD. Graphs show the average percentage values of active 
worms between treatments from three independent trials of 60-80 worms. Statistical analysis 
employed the log-rank survival test. 
 
Fig. 3. MICA restores impaired ACh neurotransmission in worms that constitutively express Aβ 
in muscle. Strain CL2006 was cultured on plates containing 5mM MICA for 72 hrs prior to 
being shifted to plates containing 5mM MICA plus either 1mM aldicarb or 0.2mM levamisole. 
Control worms were not treated with MICA. A) Time dependent paralysis of untreated or MICA 
treated [(+) MICA] worms in the presence of aldicarb. B) Time dependent paralysis of untreated 
or MICA treated [(+) MICA] worms in the presence of levamisole. 30-50 worms were used for 
each treatment in each of three independent trials. Paralysis curves were compared using log-
rank test.  
 
Fig. 4. MICA alleviates impaired chemotaxis, hypersensitivity to serotonin and reduced 
fecundity caused by neuronal expression of Aβ. L1 stage nematodes of strains CL2355 (neuronal 
Aβ) and their matched control CL2122 were cultured with or without 5mM MICA for 36 hrs at 
16
o
C plus 25
o
C for an additional 36 hrs to induce transgene expression.  A) Impairment of 
chemotaxis due to Aβ expression is significantly alleviated by exposure to 5mM MICA. B) 
Hypersensitivity toward serotonin resulting from neuronal expression of Aβ is substantially 
reduced by exposure to 5mM MICA. C) Egg production that is reduced due to Aβ expression is 
partially restored by MICA. D) Egg hatching is delayed by neuronal expression of Aβ, but this 
effect is alleviated by MICA treatment. 30-50 worms were used for each treatment in each of 
three independent trials, except for fecundity and egg hatching assays where 10 worms were 
used in each of three independent trials. Bars=Mean±SD. 
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Fig. 5. The calcium ionophore A23187 (CaI) can reverse the alleviation of Aβ-mediated 
paralysis by MICA. Aβ expression was induced in muscles of strain CL4176 by a temperature up 
shift. Various concentrations of CaI were then tested for their ability to interfere with the 
therapeutic effect of either 5mM MICA or inhibition of the dld-1 gene by RNAi on Aβ-mediated 
paralysis. Calcium chloride (CaCl2) overload was also tested for an effect on Aβ-mediated 
paralysis. A) Effect of CaI on Aβ-mediated paralysis in CL4176 worms. B) Effect of CaI on the 
ability of 5mM MICA to alleviate Aβ-mediated paralysis. C) Effect of CaI on the ability of dld-1 
RNAi to alleviate Aβ-mediated paralysis. D) Effect of CaCl2 overload on Aβ-mediated paralysis. 
The temperature for this assay was 24
o
C. Results are derived from three independent replicates 
and are given as the weighted average. Curve comparison used log-rank test. 60-80 worms were 
used for each replicate of each trial. 
 
Fig. 6. Effect of MICA and CaI on Aβ transgene and protein expression. Aβ was induced in 
muscles of strain CL4176 by a temperature up shift in worms in which the dld-1 gene was 
suppressed by RNAi, the enzyme was inhibited by 5mM MICA or 35 µM CaI was administered 
either alone or in combination with the other treatments. (A) Quantitative PCR revealed that 
none of dld-1 RNAi, MICA or CaI had any significant effect on Aβ mRNA levels. (B) A 
representative western blot of protein extracted from worms of strain CL4176 is shown in the 
bottom of panel B. Aβ was detected using Anti-Aβ antibody 6E10, with anti-actin antibody used 
to detect actin protein, which served as a normalization reference. Aβ 4kDa and 16kda peptide 
intensity levels were quantified relative to the control. Results from 3 independent experiments 
shown in the upper portion of panel B. Bars=Mean±SD.  
 
Fig. 7: MICA lower the ROS/RNS burden in C. elegans. L1 stage nematodes were cultured with 
or without 5mM MICA for 36 hours at 16
o
C, after which the temperature was upshifted to 23
o
C 
for a further 36 hours to induce expression of the Aβ transgene. Lysed worm extracts containing 
25µg protein were used in ROS/RNS and H2O2 measurements. Bars=mean±SD. (A) 
Measurement of ROS/RNS levels in worms using DCF-DA. (B) Measurement of H2O2 levels in 
worms. 
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Highlights 
 MICA decreases Aβ-mediated toxicity in C. elegans by suppressing DLD-1 activity. 
 MICA decreases Aβ-oligomerization and reduces ROS production. 
 The effect of MICA can be reversed using calcium ionophore.  
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